Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metronidazole for Periodontal Probing Depth
NCT06836401Phase 4Completed
- Sponsor
- Universidad de Salamanca
- Start
- Oct 2018
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metronidazole in periodontal disease (2 arms), sponsored by Universidad de Salamanca. Primary endpoints: Periodontal Probing Depth at 3 months and Myeloperoxidase level at 3 months. Started Oct 2018; status: completed.
02
Drugs
metronidazole
03
Conditions
periodontal disease
Beyond the preview
Go deeper on NCT06836401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836401.